-
The madit-crt trial compared the effects of implanting defibrillators with and without resynchronization therapy in patients with New York Heart Association (NYHA) functional class I and II heart failure symptoms,
-
The heartmate ii left ventricular assist device (LVAD) is a continuous flow device compared to the pulsatile flow Heartmate I.
-
The source of embolic thrombotic material in patients with cryptogenic stroke is controversial.
-
Escitalopram for menopausal hot flashes, rifaximin for IBS without constipation, herpes zoster vaccination, antiepileptics drugs and fracture risk, and FDA Actions.
-
-
Thrombosis of prosthetic heart valves is one of the most feared complications of heart-valve replacement.
-
Most prior study results of catheter ablation for atrial fibrillation (AF) have had relatively short follow-up duration.
-
Coronary artery anomalies are being recognized with increasing frequency due to the increased usage of computed tomography (CT) and magnetic resonance imaging (MRI) scans in patients with chest pain syndromes.
-
The randomized evaluation of long-term anticoagulation Therapy (RE-LY) trial was a study that compared two doses of a new direct-thrombin inhibitor, dabigatran, to warfarin for stroke prevention in patients with atrial fibrillation.
-
Mineralocorticoid receptor blockers have demonstrated improved survival in class III-IV heart-failure patients (spironolactone) and post-acute myocardial infarction patients with systolic dysfunction heart failure (eplerenone).